Issue 8, 2014

Sulfonium ions as inhibitors of the mycobacterial galactofuranosyltransferase GlfT2

Abstract

The mycobacterial cell wall possesses a core galactan moiety composed of approximately 30 galactofuranosyl residues attached via alternating β-(1→5) and β-(1→6) linkages. A bifunctional galactofuranosyltransferase, GlfT2, is one of two essential enzymes for mycobacterial cell wall biosynthesis. The enzymatic reactions catalyzed by GlfT2 undoubtedly proceed by way of a transition state that has significant oxocarbenium-ion character. In this paper, a series of sulfonium ion compounds were designed and synthesized as analogues of the donor substrate, uridine diphosphate-galactofuranose, as potential inhibitors of GlfT2. The compounds contain moieties that mimic both galactofuranose and uridine diphosphate domains, and carry a permanent positive charge to mimic the oxocarbenium ion-like transition state. These compounds were evaluated against Glf2 using a coupled spectrophotometric assay, and some were shown to be weak inhibitors of the enzyme.

Graphical abstract: Sulfonium ions as inhibitors of the mycobacterial galactofuranosyltransferase GlfT2

Supplementary files

Article information

Article type
Concise Article
Submitted
19 Feb 2014
Accepted
11 Mar 2014
First published
12 Mar 2014
This article is Open Access
Creative Commons BY-NC license

Med. Chem. Commun., 2014,5, 1130-1137

Sulfonium ions as inhibitors of the mycobacterial galactofuranosyltransferase GlfT2

J. Li and T. L. Lowary, Med. Chem. Commun., 2014, 5, 1130 DOI: 10.1039/C4MD00067F

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements